Delivery Order SPE2DB20D3505-SPE2DB24FU7T2
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,355,065 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $3,257.31 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on November 6, 2024. The award has an ultimate completion date of November 7, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4,567,171,124 units of ondansetron ODT 4 mg tablets in packages of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,811.42, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order with a completion date of February 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award is for the delivery of 4,567,372,778 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,665.15 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 25, 2025, with a completion date of February 26, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,565,965,059 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, awarded to AmerisourceBergen Drug Corporation. The $29,350.05 firm fixed-price contract was issued by the Defense Logistics Agency (DLA), a defense agency, with a performance period through September 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999...
This federal contract award is for the delivery of 4,566,601,644 units of the pharmaceutical product Ondansetron ODT 4 mg tablets in 30-count packages. The award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 3, 2024. The contract has a ceiling value of $1,293.48 and a completion date of December 4, 2024. It is a firm fixed-price delivery order contract with no set-aside requirements....
This federal contract award is for the delivery of 4,564,662,850 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $5,905.15 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of 4,565,471,054 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $25,066.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of August 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4,566,698,076 units of Ondansetron ODT 4 MG Tablet 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,184.73 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024 with a completion date of December 13, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of 4,565,481,035 tablets of Ondansetron HCL 4 mg to the Defense Logistics Agency (DLA). The $3,874.39 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024 with a completion date of August 19, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award is for the delivery of 4,565,255,906 units of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The $15,177.45 contract is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...